London HealthTech firm Reset Health mulls £60m LSE listing

London-based HeathTech start-up Reset Health is reportedly considering a £60m listing on the London Stock Exchange.

The company provides medically supervised personalised programmes for reversing type 2 diabetes and obesity, delivered via its custom-made mobile app.

The company can prescribe weight loss jabs such as Wegovy and Ozempic and claims its platform is used by roughly 500,000 people. Clients currently include some NHS trusts and Transport for London.

According to sources reported by The Times, the listing on the junior AIM exchange would look to raise £15m at a valuation of £60m.

Advisors from stockbroker Shore Capital have reportedly been onboarded to advise on the listing.

The news comes after low-cost computer manufacturer Raspberry Pi recorded one of the largest tech IPO in the recent history of the LSE earlier this month.

The round raised £166m for Raspberry Pi at a valuation of £541.6m.



Share Story:

Recent Stories


The future-ready CFO: Driving strategic growth and innovation
This National Technology News webinar sponsored by Sage will explore how CFOs can leverage their unique blend of financial acumen, technological savvy, and strategic mindset to foster cross-functional collaboration and shape overall company direction. Attendees will gain insights into breaking down operational silos, aligning goals across departments like IT, operations, HR, and marketing, and utilising technology to enable real-time data sharing and visibility.

The corporate roadmap to payment excellence: Keeping pace with emerging trends to maximise growth opportunities
In today's rapidly evolving finance and accounting landscape, one of the biggest challenges organisations face is attracting and retaining top talent. As automation and AI revolutionise the profession, finance teams require new skillsets centred on analysis, collaboration, and strategic thinking to drive sustainable competitive advantage.